Results for “stem cells”
Bone Marrow
** Bone marrow is a semi‑solid tissue inside the spongy cavities of bones that produces blood cells, stores fat, and supports immune function. **CONTENT:** ## Overview Bone marrow is a **semi‑solid, highly vascularized tissue** that fills the trabecular (spongy) portions of most bones. In mammals and birds it serves as the principal site of **hematopoiesis**, the process by which red blood cells, white blood cells, and platelets are generated throughout life. The marrow itself is a complex mixture of **hematopoietic stem and progenitor cells**, **marrow adipose tissue (fat cells)**, and a supportive network of **stromal cells**—including fibroblasts, endothelial cells, and osteoblast‑derived niche cells—that together create a microenvironment essential for stem‑cell maintenance and differentiation. In adult humans the bulk of active (red) marrow resides in the **ribs, vertebrae, sternum, pelvis, and the proximal ends of the femur and humerus**. As a person ages, some red marrow is gradually replaced by **yellow marrow**, which is rich in adipocytes and has a reduced hematopoietic capacity. Despite this conversion, the total mass of marrow remains roughly **5 % of body weight**; a 73 kg (161 lb) adult therefore carries about 3.7 kg (8 lb) of this tissue. The marrow’s dual role—as a factory for blood cells and a reservoir of energy‑rich fat—makes it a critical organ for both **immune competence** and **metabolic homeostasis**. Clinically, bone marrow is examined when patients present with unexplained anemia, infections, bleeding disorders, or systemic symptoms such as fever and weight loss. **Bone‑marrow biopsy** and aspiration are standard diagnostic tools, but they should only be performed under the guidance of a qualified hematologist or oncologist. If you experience persistent fatigue, unexplained bruising, or recurrent infections, seek professional medical evaluation promptly. ## History/Background The scientific fascination with bone marrow dates back to the 17th century, when **Marcello Malpighi** first described its vascular nature using early microscopy. In the 19th century, **Karl Ernst von Baer** and **William Hewson** identified marrow as a source of blood formation, challenging the prevailing belief that blood cells originated solely in the liver. The landmark discovery of **hematopoietic stem cells (HSCs)** by **James Till and Ernest McCulloch** in the 1960s provided the cellular basis for marrow’s regenerative capacity and paved the way for modern transplantation. Key milestones include the first successful **bone‑marrow transplant** in 1956 (performed by Dr. E. Donnall Thomas), the development of **immunophenotyping** techniques in the 1970s that allowed precise identification of marrow cell subsets, and the advent of **next‑generation sequencing** in the 2010s, which revealed the genetic landscape of marrow‑derived malignancies. These advances transformed marrow from a largely descriptive curiosity into a therapeutic cornerstone for leukemia, lymphoma, and several inherited blood disorders. ## Key Information - **Composition:** Approximately 40 % hematopoietic cells, 60 % stromal and adipose components in adult yellow marrow; red marrow contains a higher proportion of proliferating progenitors. - **Hematopoietic hierarchy:** Multipotent HSCs → multipotent progenitors → lineage‑restricted progenitors → mature erythrocytes, leukocytes, and platelets. - **Marrow niches:** **Endosteal niche** (adjacent to bone surface) maintains quiescent HSCs; **vascular niche** (near sinusoids) promotes proliferation and differentiation. - **Physiological turnover:** The human body produces roughly **2 × 10¹¹ red blood cells per day**, requiring continuous marrow activity. - **Clinical procedures:** Bone‑marrow aspiration (needle‑based sampling) and trephine biopsy (core sampling) are performed under local anesthesia; complications are rare but can include pain, bleeding, or infection. - **Transplantation:** Autologous (self‑donor) and allogeneic (donor) transplants treat a spectrum of hematologic cancers and genetic disorders; graft‑versus‑host disease remains a major risk. - **Aging effects:** With age, marrow adiposity increases, HSC function declines, and the risk of clonal hematopoiesis rises, potentially predisposing to malignancy. **When to seek care:** Persistent cytopenias (low blood counts), unexplained bone pain, or systemic symptoms should prompt evaluation by a hematology specialist. Early diagnosis of marrow pathology can dramatically improve outcomes. ## Significance Bone marrow’s importance extends beyond its role as a blood‑cell factory. It is a **central hub for immune regulation**, housing memory T cells and plasma cells that sustain long‑term immunity. The marrow microenvironment also influences **metabolic health**; excess marrow fat has been linked to osteoporosis and insulin resistance, highlighting a bidirectional relationship between skeletal and systemic metabolism. Therapeutically, marrow transplantation remains one of the most powerful curative modalities for otherwise lethal hematologic malignancies. Advances in **gene editing (CRISPR‑Cas9)** and **ex vivo HSC expansion** promise to broaden the applicability of marrow‑based therapies to genetic diseases such as sickle‑cell anemia and β‑thalassemia. Moreover, research into the marrow niche informs regenerative medicine strategies aimed at repairing bone, cartilage, and even cardiac tissue. Understanding marrow biology also informs public health. Nutritional deficiencies (e.g., vitamin B12, iron, folate) directly impair hematopoiesis, while environmental toxins (benzene, radiation) can damage marrow stem cells, leading to aplastic anemia or leukemia. Consequently, bone marrow serves as a sentinel organ reflecting both internal physiological states and external exposures. **INFOBOX:** - **Name:** Bone Marrow - **Type:** Semi‑solid connective tissue / Hematopoietic organ - **Date:** Recognized as primary hematopoietic site (19th century); modern stem‑cell concept (1960s) - **Location:** Spongy (trabecular) cavities of ribs, vertebrae, sternum, pelvis, proximal femur/humerus (adults) - **Known For:** Production of all blood cell lineages, housing hematopoietic stem cells, and serving as a niche for immune and metabolic regulation **TAGS:** hematopoiesis, stem cells, bone marrow biopsy, transplantation, immunology, metabolism, aging, medical history
ScienceCloning
** Cloning is the biotechnological and natural process of producing genetically identical organisms or cells by replicating an original genome. **CONTENT:** ## Overview Cloning refers to the creation of an organism, cell line, or DNA fragment that is **genetically identical** to a donor source. In the wild, many species achieve this through **asexual reproduction**, a strategy that bypasses the need for a mate and yields offspring that are essentially perfect copies of the parent. One well‑known natural mechanism is **parthenogenesis**, observed in insects such as aphids, reptiles like the whiptail lizard (*Aspidoscelis* spp.), and even in some sharks. In the laboratory, cloning takes on a more precise, engineered form: scientists isolate a single cell or a nucleus, insert it into an enucleated egg, and coax the resulting embryo to develop into a full organism. This **somatic cell nuclear transfer (SCNT)** technique underpins the most famous cloned mammals, including Dolly the sheep, and enables the production of **identical cell lines** for medical research, drug testing, and regenerative therapies. The cloning process can be divided into three broad categories. **Reproductive cloning** aims to generate a whole, living individual; **therapeutic cloning** (or **embryonic stem cell cloning**) seeks to produce pluripotent stem cells for tissue engineering; and **molecular cloning** focuses on replicating specific DNA fragments within bacterial plasmids for gene analysis and protein production. While the underlying principle—copying genetic material—remains constant, the methods, goals, and ethical considerations differ dramatically across these domains. ## History/Background The concept of cloning predates modern genetics. Ancient Greek philosophers such as **Aristotle** noted that certain organisms could reproduce without fertilization. However, the scientific foundation was laid in the 19th century with **Johann Friedrich Miescher’s** discovery of DNA (1869) and **Gregor Mendel’s** laws of inheritance (1865). The first true laboratory cloning experiment occurred in 1952 when **John Gurdon** successfully transplanted nuclei from frog **_Xenopus laevis_** intestinal cells into enucleated eggs, producing viable tadpoles—a landmark that earned him the Nobel Prize in Physiology or Medicine in 2012. Molecular cloning emerged in the 1970s with the development of recombinant DNA technology. In 1973, **Herbert Boyer** and **Stanley Cohen** inserted a gene into a bacterial plasmid, creating the first genetically engineered organism. This paved the way for the production of insulin, growth hormones, and countless other biologics. The most publicized milestone in reproductive cloning arrived on **July 5, 1996**, when **Dolly the sheep** was born at the Roslin Institute in Scotland, confirming that a differentiated adult somatic cell could be reprogrammed to an embryonic state. Following Dolly, a cascade of cloned mammals—goats (1999), cows (1999), and even a macaque monkey (2022)—demonstrated the expanding technical repertoire. Parallel advances in **CRISPR‑Cas9** genome editing (first reported in 2012) have now allowed precise edits to cloned genomes, merging cloning with gene therapy. ## Key Information - **Types of cloning:** - *Reproductive cloning* – produces a full organism (e.g., Dolly, 6‑cell stage embryo transferred to surrogate). - *Therapeutic cloning* – generates embryonic stem cells; a typical protocol yields a blastocyst at ~5‑day development, from which pluripotent cells are harvested. - *Molecular cloning* – uses vectors (plasmids, bacteriophages) to amplify DNA; common vectors range from 2 kb to >100 kb in size. - **Success rates:** SCNT efficiency remains low; in mammals, only **1–5 %** of transferred embryos develop to term. For example, Dolly required **277** attempts, with 29 embryos implanted. - **Key achievements:** - 1998: First cloned **bovine** (Gene) and **porcine** (Megan) births, enabling agricultural research. - 2001: Cloned **Rosa** the dog, the first canine clone, illustrating pet cloning viability. - 2013: Creation of **human embryonic stem cells** via SCNT by **Shinya Yamanaka’s** team, opening regenerative medicine pathways. - 2020: Production of **cloned endangered species** (e.g., black‑footed ferret) using frozen gametes, a potential tool for conservation. - **Technical components:** - *Enucleation* – removal of the egg’s nucleus using a micromanipulator (≈10 µm tip). - *Electrofusion* – application of a brief electric pulse (~1 kV/cm for 30 µs) to fuse donor nucleus with the oocyte. - *Culture media* – specialized solutions (e.g., KSOM) maintain embryos at 37 °C, 5 % CO₂. ## Significance Cloning reshapes multiple scientific frontiers. In medicine, therapeutic cloning supplies patient‑specific stem cells that can differentiate into heart muscle, insulin‑producing β‑cells, or retinal pigment epithelium, potentially eliminating transplant rejection. Molecular cloning underpins the biotech industry, enabling the mass production of vaccines (e.g., recombinant hepatitis B) and biologics that treat cancers and autoimmune diseases. From an ecological perspective, cloning offers a controversial but promising avenue for **biodiversity preservation**. By reviving genetic material from extinct or critically endangered species, scientists can re‑introduce lost alleles into wild populations, bolstering resilience against climate change. Ethically, cloning forces society to confront questions about identity, animal welfare, and the limits of human intervention. The low success rates and high incidence of developmental abnormalities in cloned mammals have spurred regulatory frameworks worldwide, ranging from the **EU’s Directive 98/58/EC** (1998) on animal cloning to the **U.S. National Bioethics Advisory Commission** recommendations (1999). Ultimately, cloning exemplifies the dual nature of biotechnology: a powerful tool that can accelerate discovery and healing, yet demands vigilant oversight to ensure responsible application. **INFOBOX:** - Name: Cloning (Biological Replication) - Type: Biotechnology / Natural Reproductive Strategy - Date: First successful mammalian clone – **July 5, 1996** (Dolly the sheep) - Location: Roslin Institute, Scotland (reproductive); various labs globally (molecular) - Known For: Producing genetically identical organisms, advancing stem‑cell therapy, and enabling recombinant DNA technology **TAGS:** cloning, somatic cell nuclear transfer, parthenogenesis, stem cells, recombinant DNA, biotechnology, Dolly the sheep, CRISPR *Word count: ~660*
ScienceDevelopmental Biology
** Developmental Biology is a peer‑reviewed scientific journal founded in 1959 that publishes cutting‑edge research on the molecular, cellular, and genetic mechanisms governing development, differentiation, and growth in animals and plants. **CONTENT:** ## Overview **Developmental Biology** serves as the flagship publication of the Society for Developmental Biology, delivering bi‑monthly issues that showcase the latest discoveries in embryology, stem‑cell biology, organogenesis, and evolutionary developmental biology (evo‑devo). Each issue contains original research articles, comprehensive reviews, and methodological notes that span model organisms—from *Drosophila melanogaster* and *Arabidopsis thaliana* to zebrafish (*Danio rerio*) and mouse (*Mus musculus*). By integrating molecular genetics, live‑cell imaging, single‑cell transcriptomics, and CRISPR‑based genome editing, the journal provides a platform where **mechanistic insights** into how a single fertilized egg becomes a complex multicellular organism are rigorously vetted and disseminated. The journal’s editorial board comprises internationally recognized scientists who ensure that submissions meet the highest standards of experimental design, statistical rigor, and ethical compliance. In addition to primary research, **Developmental Biology** publishes special issues that coincide with major conferences, such as the annual Society for Developmental Biology meeting, thereby fostering community dialogue and highlighting emerging trends like organoid technology and synthetic embryology. ## History/Background The origins of **Developmental Biology** trace back to the post‑World War II surge in developmental genetics, when researchers sought a dedicated outlet for studies that bridged classic embryology with the nascent field of molecular biology. The journal was officially **established in 1959** under the auspices of the newly formed Society for Developmental Biology (SDB). Its inaugural issue, released in March 1959, featured landmark papers on *Drosophila* segmentation genes and amphibian limb regeneration, setting a precedent for interdisciplinary breadth. In 1974, the journal transitioned to **Elsevier**, which introduced a modern typesetting system and expanded distribution to over 120 countries. The 1990s saw the launch of an online archive, and by 2002 the journal adopted a **twice‑monthly publication schedule**, increasing its output from six to twenty‑four issues per year. A major milestone occurred in 2015 when **Developmental Biology** introduced a **transparent peer‑review** option, allowing authors to publish reviewer reports alongside their articles—a move that underscored the journal’s commitment to openness. ## Key Information - **Publisher:** Elsevier (bi‑monthly, 24 issues / year) - **Impact Factor (2023):** 4.9, placing it in the top quartile of developmental biology journals. - **Scope:** Molecular, cellular, and genetic mechanisms of development in both **animals** and **plants**; includes evo‑devo, stem‑cell biology, and regenerative medicine. - **Article Types:** Original research, reviews, perspectives, methods papers, and **Special Issues** tied to SDB conferences. - **Submission Statistics (2022):** 2,850 manuscripts received; 22 % acceptance rate, reflecting stringent peer review. - **Digital Presence:** Full‑text PDFs and XML files available via ScienceDirect; articles indexed in PubMed, Scopus, and Web of Science. - **Community Services:** Hosts the annual **Developmental Biology Awards** for early‑career investigators and provides a **pre‑print posting policy** that permits authors to share manuscripts on bioRxiv without jeopardizing later publication. ## Significance The journal’s influence extends far beyond its citation metrics. By curating high‑quality research on **developmental mechanisms**, **Developmental Biology** has helped shape foundational concepts such as the **gene regulatory networks** that drive cell fate decisions and the **signaling gradients** that pattern embryonic axes. Papers first appearing in the journal have informed translational breakthroughs, including the derivation of induced pluripotent stem cells (iPSCs) and the engineering of organoids for disease modeling. Moreover, the journal’s emphasis on **interdisciplinary approaches** has accelerated the integration of computational modeling with experimental embryology, fostering a new generation of **systems developmental biologists**. Through its partnership with the Society for Developmental Biology, the journal also plays a pivotal role in education and outreach. It sponsors **travel grants** for students attending international conferences and publishes **educational primers** that distill complex concepts for undergraduate curricula. In an era where reproducibility and data transparency are paramount, **Developmental Biology**’s adoption of open‑review practices and mandatory data‑availability statements sets a benchmark for scholarly publishing in the life sciences. **INFOBOX:** - Name: Developmental Biology (journal) - Type: Peer‑reviewed scientific journal - Date: Established 1959; bi‑monthly publication since 2002 - Location: International (published by Elsevier, headquartered in Amsterdam, NL) - Known For: Publishing seminal research on molecular and genetic mechanisms of development; official journal of the Society for Developmental Biology **TAGS:** developmental biology, peer‑reviewed journal, Society for Developmental Biology, molecular genetics, embryology, stem cells, evo‑devo, Elsevier